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Abstract
Background:  Despite the pressing need for the creation of applications that facilitate the
aggregation of clinical and molecular data, most current applications are proprietary and lack the
necessary compliance with standards that would allow for cross-institutional data exchange. In line
with its mission of accelerating research discoveries and improving patient outcomes by linking
networks of researchers, physicians, and patients focused on cancer research, caBIG (cancer
Biomedical Informatics Grid™) has sponsored the creation of the caTRIP (Cancer Translational
Research Informatics Platform) tool, with the purpose of aggregating clinical and molecular data in
a repository that is user-friendly, easily accessible, as well as compliant with regulatory
requirements of privacy and security.
Results: caTRIP has been developed as an N-tier architecture, with three primary tiers: domain
services, the distributed query engine, and the graphical user interface, primarily making use of the
caGrid infrastructure to ensure compatibility with other tools currently developed by caBIG. The
application interface was designed so that users can construct queries using either the Simple
Interface via drop-down menus or the Advanced Interface for more sophisticated searching
strategies to using drag-and-drop. Furthermore, the application addresses the security concerns of
authentication, authorization, and delegation, as well as an automated honest broker service for
deidentifying data.
Conclusion: Currently being deployed at Duke University and a few other centers, we expect that
caTRIP will make a significant contribution to further the development of translational research
through the facilitation of its data exchange and storage processes.
Background
In order to have an impact in society, discoveries in cancer
research need to be translated into knowledge that can be
directly applied to treatment and prevention. These dis-
coveries usually start within the basic sciences, from
experiments developed at the molecular level, slowly pro-
gressing to clinical research. Although this translational
process is at the very basis of our ability to generate new
biomedical knowledge, to date few tools have been devel-
oped to successfully link the basic and clinical science
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fields in a way that researchers from both arenas can easily
make connections. More specifically, cancer research
would benefit from the development of applications that
can aggregate clinical and molecular data in a repository
that is user-friendly, easily accessible, as well as compliant
with regulatory requirements of privacy and security.
In alignment with the requirements outlined above, the
Duke Comprehensive Cancer Center (DCCC), in collabo-
ration with SemanticBits LLC, has developed the Cancer
Translational Research Informatics Platform (caTRIP,
https://cabig.nci.nih.gov/tools/caTRIP, this and all caBIG
links last current as of July 2008), a translational research
system for the Cancer Biomedical Informatics Grid
(caBIG) project [1]. caTRIP allows users to query across a
number of caBIG data services, join on common data ele-
ments (CDEs), and view their results in a user-friendly
interface. Having outcomes analysis as its initial focus,
caTRIP allows clinicians to query across data from existing
patients with similar characteristics to find treatments that
were administered with success. In doing so, caTRIP can
help inform treatment and improve patient care, as well as
enable searching for available tumor tissue, locating
patients for clinical trials, and investigating the associa-
tion between multiple predictors and their corresponding
outcomes (such as survival). Of importance, caTRIP relies
on the vast array of open source caBIG applications,
including (1) the Tumor Registry, a clinical system that is
used to collect endpoint data; (2) the cancer Text Informa-
tion Extraction System (caTIES, https://cabig.nci.nih.gov/
tools/caties), a locator of tissue resources that works via
the extraction of clinical information from free text surgi-
cal pathology reports while using controlled terminolo-
gies to populate caBIG-compliant data structures; (3)
caTissue CORE https://cabig.nci.nih.gov/tools/catis
suecore, a tissue bank repository tool for biospecimen
inventory, tracking, and basic annotation; (4) Cancer
Annotation Engine (CAE https://cabig.nci.nih.gov/tools/
cae), a system for storing and searching pathology anno-
tations; (5) caIntegrator http://gforge.nci.nih.gov/
projects/caintegrator), a tool for storing querying, and
analyzing translational data, including SNP data.
The objective of this article is to describe the caTRIP sys-
tem in relation to its objectives, overall software architec-
ture, security, implementation, usability, and future
development plans.
Case Study: Outcomes Analysis
A motivating use case for the development of caTRIP is
one of outcomes analysis, whereby a clinician can query
data from a cohort of preexisting patients to help guide
treatment of another patient. An oncologist can ask "What
are the treatments and outcomes of other patients that
have similar characteristics to my patient?" caTRIP makes
this possible on multiple levels: local, institutional,
regional, national, and beyond by leveraging grid infra-
structure to scale beyond traditional query systems.
Consider an example of a patient with a breast lump
approaching an oncologist for treatment at a tertiary care
facility. The patient has been told by her local physician
that the tumor she has is not uncommon, but difficult to
manage. The oncologist reviews the medical documents
from the outside institution and recognizes an entity that
is well-equipped to handle a lobular carcinoma of the
breast. What is slightly odd is that this tumor has an inter-
mediate nuclear grade and has been further designated as
a "pleomorphic lobular carcinoma". The oncologist is
familiar with the medical literature on the topic and rec-
ognizes that in certain circumstances such an entity may
exhibit biologic behavior akin to an invasive ductal tumor
(rather than that of a typical lobular). Paralleling the odd
histologic finding is an additional finding that the tumor
is negative for estrogen receptor (ER) expression, negative
for progesterone receptor (PR) expression, but strongly
positive for human epidermal growth factor receptor 2
(Her-2/neu) overexpression. This profile is very uncharac-
teristic for a lobular carcinoma of the breast. Thinking that
the tumor may have been misclassified, the oncologist has
the pathology material reviewed again and re-runs the
molecular studies to confirm the receptor studies reported
from the outside institution. To complicate matters, the
reviewing pathologist reclassifies the tumor as a typical
lobular carcinoma (not pleomorphic), but the receptor
study profiles (ER, PR) and Her-2/neu status remain
unchanged. Now there is no diagnostic correlate for the
receptor profile results. Lobular tumors (particularly typi-
cal ones) are nearly always positive for ER and PR receptor
(and usually strongly so) and negative for Her-2/neu over-
expression.
As an example, at Duke, the Breast Pathology service will
typically see one or two such cases per year at most. The
expected biologic behavior and sensitivity to various treat-
ment protocols are unknown in such cases. The body of
literature on this particular scenario of findings is still
maturing [2-5]. The fact of the matter is that even a large
tertiary care facility will rarely come across such tumors.
caTRIP provides a mechanism to examine all those
patients who have been seen at any institution where
caTRIP has been deployed and identify the cohort of
patients that matches the specified criteria. It is a matter of
a few minutes, at most, to construct a query that narrows
the cohort to patients that have lobular tumors of the
breast, are ER negative, PR negative, and Her-2/neu over-
expressed (Figure 1). Furthermore, the type of treatment
employed and the time to recurrence or death are easily
captured as part of the result set by drawing upon the
Tumor Registry as an additional data source. This permitsBMC Medical Informatics and Decision Making 2008, 8:60 http://www.biomedcentral.com/1472-6947/8/60
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a level of decision in the clinic – heretofore impossible
with prior technologies. Running such a query at Duke
returns very few cases because of the relative rarity of such
clinical phenotypes. However, caTRIP is grid-enabled,
and, if deployed at Cancer Centers across the country as
part of the NCI's caBIG initiative, the statistical power
could easily increase by multiple orders of magnitude.
Rather than relying on single-institution or limited data
sets published in the literature, an oncologist now has
access to a rich live data set that can provide strong statis-
tically significant data in mere minutes.
While the preceding scenario focuses on facilitating clini-
cal care, caTRIP is adept at enabling research as well. Con-
sider a follow-up situation in which a researcher would
like to take that cohort of patients that have lobular carci-
noma and Her-2/neu overexpression and compare them
to a cohort that have ductal tumors that also overexpress
Her-2/neu, as well as to a third group that have lobular
tumors but not overexpress Her-2/neu. DNA arrays can be
used to test for the presence of hundreds or even thou-
sands of gene sequences in relatively short order if tissue
samples are available. caTRIP can cross-query linked
biospecimen repositories to identify samples that are
available for the three cohorts of patients and retrieve
samples that match specified criteria (e.g. frozen diseased
tissue with match adjacent normal tissue). With informat-
ics solutions like caTRIP and newer molecular technolo-
gies like DNA arrays, the time and effort to develop new
diagnostic and prognostic markers of disease can be sig-
nificantly reduced.
Screenshot of the Simple Interface depicting a outcomes analysis translational query Figure 1
Screenshot of the Simple Interface depicting a outcomes analysis translational query.BMC Medical Informatics and Decision Making 2008, 8:60 http://www.biomedcentral.com/1472-6947/8/60
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Design Objectives
The objectives and sample questions that caTRIP is
designed to address include:
1. Allow for the search of available tumor tissue for
patients with factors of interest. A typical question to be
answered by caTRIP would thus be: "What are all the tissue
specimens from Her-2/neu positive patients that have a primary
tumor in the breast and are BRCA1 positive?"
2. Identify predictors contributing to increased or
decreased survival among a subset of cancer patients.
caTRIP should answer questions such as: "What are all the
ER positive patients that have survived breast cancer after radi-
ation treatment?"
3. Determine the distribution over time of a number of
factors that may contribute to or reflect progression of a
disease state: "Does a change in pathology biomarkers over
time contribute to recurrence or death?"
4. Determine the association between a multitude of clin-
ical predictors and their respective post-operative out-
comes, such as "Does a change in ER or PR status before and
after surgery correlate with other factors?"
5. Identify patients eligible for participation in clinical tri-
als that meet a pre-defined set of inclusion and exclusion
criteria, such as "List all patients that are triple negative (ER,
PR, and Her-2/neu negative)."
6. Identify pathology reports of interest, such as "Show me
all pathology reports for Her-2/neu positive patients with a lob-
ular carcinoma."
In addition, it is important that the system provide secu-
rity and confidentiality levels in accordance with HIPAA
(Health Insurance Portability and Accountability Act) and
part 11 FDA regulations.
Implementation
Technical Requirements
Our high level scientific use cases were in part motivated
by the need to access a variety of data types stored in a
number of data systems at Duke. The Medical Assistant on
the World Wide Web (MAW3), data from the Genetic
Modifiers of BRCA 1/2 study (GEMS), and Tumor Registry
data sources feed caTRIP pathology, clinical, tissue bank-
ing, single nucleotide polymorphism (SNP), and treat-
ment/endpoint data. From this baseline, we defined the
outcomes analysis use cases that feed into the system and
application requirements that define the overall set of fea-
tures that caTRIP implements (see Background for scien-
tific use cases).
The system requirements primarily relate to development
in the Cancer Biomedical Informatics Grid (caBIG) initia-
tive [1]. caBIG has outlined a rigorous set of requirements
related to interoperability that span the categories of leg-
acy, bronze, silver, and gold compatibility. Silver compat-
ibility places requirements on both the data elements that
are exposed to/by caTRIP, as well as the application pro-
gramming interfaces (APIs). Data elements leveraged in
caTRIP must be defined as common data elements
(CDEs) registered in the Cancer Data Standards Reposi-
tory (caDSR, http://ncicb.nci.nih.gov/NCICB/infrastruc
ture/cacore_overview/cadsr). Each CDE must have one or
more semantic concepts registered in the Enterprise
Vocabulary Service (EVS, http://ncicb.nci.nih.gov/
NCICB/infrastructure/cacore_overview/vocabulary). This
combination of defining the structure of the data, as well
as the underlying semantic concepts describing the mean-
ing of the data provide caTRIP with semantically rich
information models to query upon. However, in order to
query across different data systems, it is critical that the
CDEs be harmonized. This allows for data to be aggre-
gated and presented to the user, as well as provides com-
mon CDEs, or keys, to join on. One way to catalogue these
foreign CDEs is through a Master Person Index, which
would provide a common identifier to link patients across
systems [6]. It is possible, though not without challenges,
to identify and link patients within a single institution
using an institutional medical record number (MRN).
However, queries that join on patients across institutional
boundaries can be quite challenging.
Compatibility of the APIs in caTRIP falls more squarely
into caBIG gold compatibility, which has not fully been
defined by the caBIG program as of yet. All data that is
accessible to caTRIP must be exposed via caGrid data serv-
ices [7]. This means that the data is queriable via a well-
defined, standards-based interface that accepts queries via
the caGrid Common Query Language (CQL), which
describes the query in object-oriented terms correspond-
ing to the registered CDEs. Finally, there are also system
requirements related to security, which include authenti-
cating users based on credentials and authorizing users to
access data.
Software architecture
caTRIP is developed as an N-tier architecture with three
primary tiers: domain services, the distributed query
engine (DQE), and the graphical user interface (Figure 2).
The domain services are grid services that expose informa-
tion models that encapsulate the underlying data. The dis-
tributed query engine takes as input a distributed
common query language (DCQL) query, decomposes it
into individual common query language (CQL) queries,
issues those queries to the domain services, joins/aggre-
gates the results, and returns the final results to the caller.BMC Medical Informatics and Decision Making 2008, 8:60 http://www.biomedcentral.com/1472-6947/8/60
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The graphical user interface (GUI) provides a metadata-
driven interface for building and running DCQL. It also
provides an interface for saving and searching for queries.
Another important goal for caTRIP is to leverage existing
technologies wherever possible. These include:
￿ Globus 4.1 for the underlying messaging stack
￿ caGrid 1.0 for the underlying service infrastructure
￿ Introduce for service creation
￿ Index Service for discovering services on the grid
￿ Authentication Service to authenticate users using their
institutional credentials
￿ Dorian to obtain a grid user proxy
￿ Grid Grouper to authorize users to access data based on
groups
￿ Common Security Module (CSM) for plugging authoriza-
tion into the data service
￿  Cancer Data Standards Repository (caDSR) for storing
common data elements (CDEs)
High-level view of the caTRIP architecture, including Domain Services, Distributed Query Engine, and Graphical User Interface Figure 2
High-level view of the caTRIP architecture, including Domain Services, Distributed Query Engine, and Graph-
ical User Interface.BMC Medical Informatics and Decision Making 2008, 8:60 http://www.biomedcentral.com/1472-6947/8/60
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￿ Enterprise Vocabulary Services (EVS) for storing semantic
concepts
￿ Hibernate for an object-relational mapping
￿ Oracle and MySQL for backend relational databases
More information can be found in the caTRIP architecture
document and UML models:
￿ http://gforge.nci.nih.gov/plugins/scmcvs/cvsweb.php/
catrip/documentation/technical_guide/
caTRIP_Technical_Guide.doc?cvsroot=catrip
￿ http://gforge.nci.nih.gov/plugins/scmcvs/cvsweb.phca-
trip/documentation/models/caTRIP_UML.doc?cvs
root=catrip
Implementation at Duke
We deployed caTRIP at Duke to leverage data from the
Genetic Modifiers of BRCA1 and BRCA2 study in the
Duke Breast Specialized Program of Research Excellence
(SPORE). The goal of the GEMS investigation is to identify
factors that influence the incidence of breast cancer in
germline BRCA1/2 mutation carriers. To this end, we
deployed tissue banking and pathology data from MAW3
into caTissue CORE, CAE, and caTIES; treatment, recur-
rence, and endpoint data from our Tumor Registry into a
grid service; and SNP data from flat files into caIntegrator.
These services were secured and then exposed to the
caTRIP interface. This deployment allowed us to answer
all of the domain questions that are found in the Design
Objectives section of this article. Users of this pilot
deployment included a set of pathologists and clinicians
who provided feedback that guided the development,
providing important feedback such as the use of menu-
drive interfaces that require little knowledge of the back-
end data instead of drag-and-drop interfaces that do
require such knowledge.
Results and discussion
Graphical User Interface
The Graphical User Interface (GUI) is a Java Swing-based
thick client that can be accessed via Java WebStart http://
java.sun.com/products/javawebstart/. It provides the user
with the ability to construct, execute, and share distrib-
uted queries in a graphical fashion. There are two primary
ways to construct queries: the Simple Interface is a more
limited, yet powerful way to build queries using drop-
down menus, and the Advanced Interface is a flexible way
to build queries using drag-and-drop.
Simple Interface
The "Simple Interface" was developed to target the non-
technical users such as a clinician. Queries are constructed
using drop-down menus to add filters, AND/OR groups,
and return attributes (Figures 1 and 3). Available services
are selected via a configuration file, as well as the CDEs
that make up the drop-down menu items for filters and
return attributes. Joins across these services are performed
using common identifiers. Specifically, in caTRIP, we use
the (optionally) deidentified Medical Record Number
(MRN) of patients to join and aggregate data. The data
models of the underlying services are composed of poten-
tially complex classes, attributes, and associations
between the classes (see Figure 4). In order to construct
queries that span multiple classes and associations, the
Simple Interface leverages a configuration file that
describes the outbound path from each class to the MRN,
as well as the inbound path to each filterable/returnable
CDE. This enables the automated logic that would nor-
mally be performed by a user manually selecting all of the
associations necessary to perform a query.
Advanced Interface
The "Advanced Interface" was developed to target a data
technician who may wish to perform more complex que-
ries. Queries are constructed by dragging classes onto a
canvas, drawing associations between them, and adding
filters along the way (Figure 4). Because the logic of how
to traverse the information space is not built-in like it is
with the "Simple Interface", users must manually create
the association paths to the classes/attributes that they
would like to filter on, as well as those they would like to
perform cross-service foreign joins with. This allows users
to perform queries not supported by the "Simple Inter-
face" but adds an extra level of complexity.
Distributed Query Engine
The Distributed Query Engine (DQE) provides the logic to
perform a query across different caGrid data services. The
caTRIP team developed a distributed query engine, which
was later adopted into the caGrid 1.0 toolkit as the Feder-
ated Query Processor (FQP) module. Currently, the DQE
is available for use by the general caBIG community and
is currently being leveraged by the Cancer Bench to Bed-
side (caB2B) project http://gforge.nci.nih.gov/projects/
cab2b/. It takes as input a Distributed Common Query
Language (DCQL) query, breaks it into separate Common
Query Language (CQL) queries, issues those queries to the
appropriate underlying data services, receives the results,
performs joins, aggregates data, and returns the results.
The DQE is built as a Java service and can be deployed as
a grid service.
Domain Services
The domain services themselves can be further divided
into a number of tiers, including a relational database
management system (RDBMS), Hibernate, Common
Query Language processor http://gforge.nci.nih.gov/pluBMC Medical Informatics and Decision Making 2008, 8:60 http://www.biomedcentral.com/1472-6947/8/60
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gins/scmcvs/cvsweb.php/cagrid-1-0/Documentatiodocs/
DataService/Technical/dataServiceTechnical
Guide.doc?cvsroot=cagrid-1-0, and grid service. Hiber-
nate provides an object-oriented abstraction of the under-
lying relational database, exposing tables and columns as
classes and attributes in a flexible, configurable manner
http://www.hibernate.org/. The CQL processor translates
a CQL query based upon common data elements and
their associations into a Hibernate Query Language
(HQL) query. This is a relatively complex mapping
because CQL and HQL have much different syntaxes.
Finally, the grid service provides a standards-based entry
point to issue a CQL query. caGrid https://
cabig.nci.nih.gov/workspaces/Architecture/caGrid/ pro-
vides the underlying technology stack for the grid service,
which itself is based upon Globus 4.1 http://www.glo
bus.org/.
Security
caTRIP leverages the caGrid 1.0 infrastructure, which pro-
vides robust security for a distributed grid environment
(Figure 5).
Security: Authentication
The first step in the security workflow is authentication,
which is the process by which a trusted organization
asserts a user is who they claim to be. This is implemented
using the caGrid Authentication Service. The goal is for the
user to obtain a grid user certificate to be used in authori-
zation. The user submits their credentials (user name and
password) to the AuthenticationService, which has an
institutional identity provider (IdP) plug-in. This compo-
nent performs the necessary steps to determine that the
user's credentials are valid. In the case of the Duke IdP
plugin, the user name and password are validated against
Steps to perform a query in the caTRIP Simple Interface Figure 3
Steps to perform a query in the caTRIP Simple Interface.BMC Medical Informatics and Decision Making 2008, 8:60 http://www.biomedcentral.com/1472-6947/8/60
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a Duke Domain Controller, which uses NT Security. This
means that a user can log in with the same Cancer Center
credentials they use to log in to their workstation. Once
validated, the AuthenticationService returns a Security
Assertion Markup Language (SAML) document http://
www.oasis-open.org/committees/download.php/14361/
sstc-saml-tech-overview-2.0-draft-08.pdf to the user,
which asserts that the user is who they claim to be. The
SAML Assertion can then be passed off to a Dorian Service
to generate a grid user certificate. All of these interactions
are handled for the user by the caTRIP application.
Security: Authorization
The second step in the security workflow is authorization,
which is the process by which a system grants the user
access to specific resources. This is implemented using the
Common Security Module (CSM) plug-in to the grid data
service. The CSM {Phillips, 2006} is an open source
toolkit that provides a flexible way to provision users and
make authorization decisions. When a data field is
accessed on behalf of the user, an authorization structure
is queried to determine whether the user has permission
to access it. If not, then a security exception is returned to
the client. Authorization is made possible because trust
exists between the service serving the data resource and
the AuthenticationService.
Delegation and Foreign CDEs
An alternate flow in the security workflow is delegation,
which is the process by which a service acts on behalf of
the user. This impacts caTRIP because the distributed
query engine can be run as a service, so it must query the
Example Advanced Interfacing, depicting the potential complexity of distributed queries Figure 4
Example Advanced Interfacing, depicting the potential complexity of distributed queries.BMC Medical Informatics and Decision Making 2008, 8:60 http://www.biomedcentral.com/1472-6947/8/60
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domain services using the user's certificate. The final
implementation will likely leverage the DelegationService
from the Globus project. The user will signal the Delega-
tionService that it is permissible for a collocated service to
act on the user's behalf. In the meantime, the distributed
query engine is collocated with graphical user interface, so
it simply passes the user's credentials to the data services
identified in the distributed query. This bypasses some of
the business rules defined by delegation, such as the
number of delegation hops allowed by the user, but it is
sufficient to meet caTRIP use cases.
Another change on the security workflow is the use of
"foreign CDEs" for the purpose of joining data. It is con-
ceivable that a user does not have permission to view a
CDE that is used for joining between two different
domain services. The classic example of this is to join
patients across services using the Medical Record Number.
In this case, a special security workflow must be under-
taken during authorization. A level of trust is maintained
between the distributed query engine service and the
domain service such that foreign CDEs are returned to the
DQE service with the understanding that the delegated
user is not authorized to view them but is authorized to
join on them. This workflow is only possible if the DQE is
not collocated with the client application.
Automated Honest Broker Service
The primary goal of caTRIP is to provide users access to
diverse datasets that cross domains and data sources. One
challenge that arises from this is deidentifying datasets
that are managed by different groups, which especially
affects deidentifying foreign CDEs (MRNs) that are used
to link across different datasets. A typical scenario for
High-level overview of the caGrid security architecture http://cagrid.org Figure 5
High-level overview of the caGrid security architecture http://cagrid.org.BMC Medical Informatics and Decision Making 2008, 8:60 http://www.biomedcentral.com/1472-6947/8/60
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cross-dataset deidentification is for an IRB appointed indi-
vidual to collect each dataset and deidentify them all at
once, tossing away the keys to the Protected Health Infor-
mation (PHI). This approach is not scalable in a distrib-
uted environment because it requires a middle-man to
perform the deidentification. Whenever a new dataset is
added to the system, all previously existing data sets must
be deidentified again. To address this in caTRIP, we devel-
oped an Automated Honest Broker Service (AHBS), which
performs the tasks once performed by a human appointed
by the Institutional Review Board. A data owner program-
matically submits PHI (e.g. an MRN) to the AHBS using a
secure connection. The AHBS generates a random key,
associates it internally in a database to the PHI (which can
be encrypted), and then returns the key to the data owner.
The data owner then can deidentify his dataset by replac-
ing the PHI with the random key. When more than one
data owner/dataset is involved, the AHBS will always
return the same random key for the same PHI. In this way,
diverse, distributed datasets can be deidentified using the
same keys.
Example from the Duke Implementation
The following example illustrates how caTRIP would con-
struct and execute a user query that joins disparate data-
sets. A user at Duke could ask the question, "What are all
of the available tissue specimens from the breast obtained
from patients tested for positive expression of the estrogen
receptor?" The distributed query engine would first fetch
all of the patient medical record numbers from the Clini-
cal Annotation Engine (CAE) service that have estrogen
receptor expression annotated as positive. It would then
issue a query to the caTissue CORE service for tissue spec-
imens that are marked available, were collected from the
tissue site of breast, and were obtained from patients that
have medical record numbers that match those returned
from the previous query. The results would be a list of tis-
sue specimens, including their barcodes, location, size,
etc. The single query issued to the distributed query
engine would look like this:
1  <DCQLQuery xmlns = "http://caGrid.caBIG/1.0/
gov.nih.nci.cagrid.dcql">
2  <TargetObject name = "http://edu.wustl.catis
suecore.domainobject.impl.TissueSpecimenImpl" serv-
iceURL = "http://localhost:8080/wsrf/services/cagrid/
CaTissueCore">
3  <Group logicRelation = "AND">
4  <Attribute name = "available" predicate =
"EQUAL_TO" value = "true"/>
5  <Association name = "http://edu.wustl.catis
suecore.domainobject.impl.SpecimenCharacteristic
sImpl" roleName = "specimenCharacteristics">
6  <Attribute name = "tissueSite" predicate =
"LIKE" value = "breast%"/>
7 </Association>
8  <Association name = "http://edu.wustl.catis
suecore.domainobject.impl.SpecimenCollection
GroupImpl" roleName = "specimenCollectionGroup">
9  <Association name = "http://edu.wustl.catis
suecore.domainobject.impl.ClinicalReportImpl"
roleName = "clinicalReport">
10  <Association name = "http://edu.wustl.cati
ssuecore.domainobject.impl.ParticipantMedicalIdentifi
erImpl" roleName = "participantMedicalIdentifier">
11 <ForeignAssociation>
12 <JoinCondition>
13 <LeftJoin>
14
<Object>edu.wustl.catissuecore.domai
nobject.impl.ParticipantMedicalIdentifierImpl</Object>
15
<Property>medicalRecordNumber</
Property>
16 </LeftJoin>
17 <RightJoin>
18
<Object>edu.duke.catrip.cae.domain.g
eneral.ParticipantMedicalIdentifier</Object>
19
<Property>medicalRecordNumber</
Property>
20 </RightJoin>
21 </JoinCondition>
22 <ForeignObject  name  =
"http:edu.duke.catrip.cae.domain.general.ParticipantMe
dicalI dentifier" serviceURL = "http://localhost:8080/
wsrf/services/cagrid/CAE">BMC Medical Informatics and Decision Making 2008, 8:60 http://www.biomedcentral.com/1472-6947/8/60
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23  <Association name = "http://
edu.duke.catrip.cae.domain.general.Participant"
roleName = "participant">
24  <Association name =
"http:edu.pitt.cabig.cae.domain.general.AnnotationEvent
Pa rameters" roleName = "annotationEventParameter-
sCollection">
25  <Association name =
"http:edu.pitt.cabig.cae.domain.breast.BreastCancerBiom
ark ers" roleName = "annotationSetCollection">
26  <Attribute name = "estrogenRe-
ceptor" predicate = "LIKE" value = "POSITIVE%"/>
27 </Association>
28 </Association>
29 </Association>
30 </ForeignObject>
31 </ForeignAssociation>
32 </Association>
33 </Association>
</Association>
</Group>
</TargetObject>
</DCQLQuery>
Note on line 1 that the query is rooted at caTissue CORE,
where available specimens are filtered on line 4 and spec-
imens from the tissue site of "breast" are filtered on line 6.
Lines 11–31 define the foreign association between caTis-
sue CORE and CAE. The medical record numbers (MRNs)
of each service are joined on lines 12–21 by defining the
left join criteria to be the MRN from caTissue CORE and
the right join criteria to the be MRN from CAE. Line 22
selects the foreign service to be CAE, from which patients
with estrogen receptor expression marked as positive are
filtered on line 26. The query itself is unfolded and exe-
cuted inside-out by the distributed query engine, CAE
being the first service to be queried and the results used to
query caTissue CORE. Note also that the association paths
of the objects are defined within the query on lines 5, 8, 9,
10, 23, 24, and 25, the logic of which is hidden from the
users who are simply selecting data elements to query
upon and return. The abbreviated results would look like
this:
1 <queryResults  targetClassname  =
"http:edu.wustl.catissuecore.domainobject.impl.TissueSp
eci menImpl">
2  <ns1:ObjectResult xmlns:ns1 = "http://CQL.caBIG/1/
gov.nih.nci.cagrid.CQLResultSet">
3  <ns2:TissueSpecimen id = "397" type = "Fixed Tissue
Block" available = "true" positionDimensionOne = "20"
positionDimensionTwo = "22" barcode = "ISBN-10
AB00-0013XY" comments = "TISSUE IN FORMALIN 30"
activityStatus = "Active" quantityInGram = "0.7" availa-
bleQuantityInGram = "0.199999988079071" xmlns:ns2
= "gme://caCORE.cabig/3.0/edu.wustl.catis
suecore.domainobject"/>
4 </ns1:ObjectResult>
5  <ns2:ObjectResult xmlns:ns2 = "http://CQL.caBIG/1/
gov.nih.nci.cagrid.CQLResultSet">
6  <ns3:TissueSpecimen id = "406" type = "Fixed Tissue
Block" available = "true" positionDimensionOne = "19"
positionDimensionTwo = "14" barcode = "ISBN-10
AB00-0043XY" comments = "STRONG FAMILY HISTORY
FOR BRCA MUTATIONS" activityStatus = "Active" quan-
tityInGram = "6.75" availableQuantityInGram = "6.25"
xmlns:ns3 = "gme://caCORE.cabig/3.0/edu.wustl.catis
suecore.domainobject"/>
7 </ns2:ObjectResult>
8  <ns3:ObjectResult xmlns:ns3 = "http://CQL.caBIG/1/
gov.nih.nci.cagrid.CQLResultSet">
9  <ns4:TissueSpecimen id = "411" type = "Fixed Tissue
Block" available = "true" positionDimensionOne = "21"
positionDimensionTwo = "7" barcode = "ISBN-10 AB00-
0063XY" comments = "NO MORE WHOLE BLOOD"
activityStatus = "Active" quantityInGram = "42.75" avail-
ableQuantityInGram = "42.25" xmlns:ns4 =
"gme:caCORE.cabig/3.0/
edu.wustl.catissuecore.domainob ject"/>
10 </ns3:ObjectResult>
...
11 </queryResults>
Note that line 1 defines the type of object being returned
in the query results, and that the results themselves foundBMC Medical Informatics and Decision Making 2008, 8:60 http://www.biomedcentral.com/1472-6947/8/60
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on lines 3, 6, and 9 are each of the objects that match the
query criteria with data elements of interest embedded
within them as attributes.
Conclusion
caTRIP is being implemented in a phased-development
cycle, meeting certain objectives at each point to provide
utility as the program is extended. It is currently in its sec-
ond phase of development. Phase one concluded the pilot
development activities of caTRIP, providing a baseline
architecture and proof-of-concept user interface. End user
training was provided on a limited basis for the small
multidisciplinary breast oncology group using live dem-
onstrations and basic instructions provided through e-
mail messages. Feedback was collected through e-mail as
well. The multidisciplinary group was given direct access
to the primary software developers and technical experts
during this period. In phase two, we plan to deploy
caTRIP-II along with enhancements determined through
end user interaction. Furthermore, we are also in the proc-
ess of engaging different groups at Duke to adopt caTRIP
to help meet their research goals.
In phase one of caTRIP, use cases focused on intra-institu-
tional problems, tearing down the silos of data-oriented
systems in a single cancer center. In future iterations we
plan to extend caTRIP to tackle cross-institutional use
cases. This involves extending the caTRIP interface and
distributed query engine to support aggregation of data
from services that expose common data elements. For
example, a motivating use case amongst prospective
adopters is to aggregate treatment, endpoint, pathology,
and tissue banking data from a number of different cancer
centers. This will allow researchers and clinicians to
expand their queries and answer questions that they pre-
viously could not at their own institution. Furthermore,
we plan to integrate caTRIP with analytics, specifically
focusing on microarray analysis. The caBIG gene expres-
sion database, caArray, is a rich source of central or distrib-
uted gene expression data, which itself can be tied to
clinical data, such as pathology biomarkers. This microar-
ray data can be analyzed and visualized dynamically using
services provided by other caBIG applications, such as
geWorkbench {Califano 2006 http://apiii.upmc.edu/
abstracts/posterarchive/2006/watkinson.html}, GenePat-
tern [8], and Bioconductor[9]. This notion of building
workflows based upon queries designed using caTRIP's
simple interface can provide a powerful tool for both
researchers and clinicians. Finally, we also plan to
enhance the user interface, providing more sophisticated
reporting and data mining functionality. All of these fea-
tures will be driven by end-user requirements of the adop-
ter sites, which is a critical facet to the caBIG initiative.
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